484 related articles for article (PubMed ID: 25005581)
1. A novel vesicular transdermal delivery of nifedipine - preparation, characterization and in vitro/in-vivo evaluation.
Yasam VR; Jakki SL; Natarajan J; Venkatachalam S; Kuppusamy G; Sood S; Jain K
Drug Deliv; 2016; 23(2):619-30. PubMed ID: 25005581
[TBL] [Abstract][Full Text] [Related]
2. Omega 3 fatty acid-enriched nanoemulsion of thiocolchicoside for transdermal delivery: formulation, characterization and absorption studies.
Kumar D; Ali J; Baboota S
Drug Deliv; 2016; 23(2):591-600. PubMed ID: 24892633
[TBL] [Abstract][Full Text] [Related]
3. Enhanced bioavailability of exemestane via proliposomes based transdermal delivery.
Jukanti R; Sheela S; Bandari S; Veerareddy PR
J Pharm Sci; 2011 Aug; 100(8):3208-3222. PubMed ID: 21404279
[TBL] [Abstract][Full Text] [Related]
4. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
[TBL] [Abstract][Full Text] [Related]
5. Formulation and evaluation of proniosomes containing lornoxicam.
Madan JR; Ghuge NP; Dua K
Drug Deliv Transl Res; 2016 Oct; 6(5):511-8. PubMed ID: 27255375
[TBL] [Abstract][Full Text] [Related]
6. Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design.
Aboelwafa AA; El-Setouhy DA; Elmeshad AN
AAPS PharmSciTech; 2010 Dec; 11(4):1591-602. PubMed ID: 21063815
[TBL] [Abstract][Full Text] [Related]
7. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.
Qumbar M; Ameeduzzafar ; Imam SS; Ali J; Ahmad J; Ali A
Biomed Pharmacother; 2017 Sep; 93():255-266. PubMed ID: 28738502
[TBL] [Abstract][Full Text] [Related]
8. Novel diphenyl dimethyl bicarboxylate provesicular powders with enhanced hepatocurative activity: preparation, optimization, in vitro/in vivo evaluation.
Aburahma MH; Abdelbary GA
Int J Pharm; 2012 Jan; 422(1-2):139-50. PubMed ID: 22079716
[TBL] [Abstract][Full Text] [Related]
9. Transdermal delivery of oxybutynin chloride proniosomal gels for the treatment of overactive bladder.
Rajabalaya R; David SR; Chellian J; Xin Yun G; Chakravarthi S
Drug Deliv; 2016 Jun; 23(5):1578-87. PubMed ID: 26634274
[TBL] [Abstract][Full Text] [Related]
10. Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam.
Al-Mahallawi AM; Abdelbary AA; Aburahma MH
Int J Pharm; 2015 May; 485(1-2):329-40. PubMed ID: 25796122
[TBL] [Abstract][Full Text] [Related]
11. Single Intravenous Dose of Novel Flurbiprofen-Loaded Proniosome Formulations Provides Prolonged Systemic Exposure and Anti-inflammatory Effect.
Verma P; Prajapati SK; Yadav R; Senyschyn D; Shea PR; Trevaskis NL
Mol Pharm; 2016 Nov; 13(11):3688-3699. PubMed ID: 27632682
[TBL] [Abstract][Full Text] [Related]
12. Elastic liposomes mediated transdermal delivery of an anti-hypertensive agent: propranolol hydrochloride.
Mishra D; Garg M; Dubey V; Jain S; Jain NK
J Pharm Sci; 2007 Jan; 96(1):145-55. PubMed ID: 16960826
[TBL] [Abstract][Full Text] [Related]
13. Sublingual fast dissolving niosomal films for enhanced bioavailability and prolonged effect of metoprolol tartrate.
Allam A; Fetih G
Drug Des Devel Ther; 2016; 10():2421-33. PubMed ID: 27536063
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous delivery of econazole using microemulsion as vehicle: formulation, evaluation and vesicle-skin interaction.
Ge S; Lin Y; Lu H; Li Q; He J; Chen B; Wu C; Xu Y
Int J Pharm; 2014 Apr; 465(1-2):120-31. PubMed ID: 24530389
[TBL] [Abstract][Full Text] [Related]
15. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation.
Freag MS; Elnaggar YS; Abdallah OY
Int J Pharm; 2013 Sep; 454(1):462-71. PubMed ID: 23830765
[TBL] [Abstract][Full Text] [Related]
16. Development of nitrendipine transdermal patches: in vitro and ex vivo characterization.
Gannu R; Vishnu YV; Kishan V; Rao YM
Curr Drug Deliv; 2007 Jan; 4(1):69-76. PubMed ID: 17269919
[TBL] [Abstract][Full Text] [Related]
17. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
[TBL] [Abstract][Full Text] [Related]
18. Nano-proniosomes enhancing the transdermal delivery of mefenamic acid.
Wen MM; Farid RM; Kassem AA
J Liposome Res; 2014 Dec; 24(4):280-9. PubMed ID: 24779560
[TBL] [Abstract][Full Text] [Related]
19. Proniosomal gel for transdermal delivery of lornoxicam: optimization using factorial design and in vivo evaluation in rats.
Shah H; Nair AB; Shah J; Bharadia P; Al-Dhubiab BE
Daru; 2019 Jun; 27(1):59-70. PubMed ID: 30701460
[TBL] [Abstract][Full Text] [Related]
20. Formulation and evaluation of ethosomes for transdermal delivery of lamivudine.
Jain S; Tiwary AK; Sapra B; Jain NK
AAPS PharmSciTech; 2007 Dec; 8(4):E111. PubMed ID: 18181532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
